294 related articles for article (PubMed ID: 28281925)
41. Prion protein amino acid sequence influences formation of authentic synthetic PrP
Block AJ; York TC; Benedict R; Ma J; Bartz JC
Sci Rep; 2023 Jan; 13(1):441. PubMed ID: 36624174
[TBL] [Abstract][Full Text] [Related]
42. Prion Strains Differ in Susceptibility to Photodynamic Oxidation.
Kostelanska M; Holada K
Molecules; 2022 Jan; 27(3):. PubMed ID: 35163872
[TBL] [Abstract][Full Text] [Related]
43. Fukuoka-1 strain of transmissible spongiform encephalopathy agent infects murine bone marrow-derived cells with features of mesenchymal stem cells.
Cervenakova L; Akimov S; Vasilyeva I; Yakovleva O; McKenzie C; Cervenak J; Piccardo P; Asher DM
Transfusion; 2011 Aug; 51(8):1755-68. PubMed ID: 21303371
[TBL] [Abstract][Full Text] [Related]
44. Species-barrier phenomenon in prion transmissibility from a viewpoint of protein science.
Hagiwara K; Hara H; Hanada K
J Biochem; 2013 Feb; 153(2):139-45. PubMed ID: 23284000
[TBL] [Abstract][Full Text] [Related]
45. The cellular and pathologic prion protein.
Gill AC; Castle AR
Handb Clin Neurol; 2018; 153():21-44. PubMed ID: 29887138
[TBL] [Abstract][Full Text] [Related]
46. Agent-specific Shadoo responses in transmissible encephalopathies.
Miyazawa K; Manuelidis L
J Neuroimmune Pharmacol; 2010 Mar; 5(1):155-63. PubMed ID: 20112073
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein.
Kim DH; Lee HM; Ryou C
J Korean Med Sci; 2014 Dec; 29(12):1604-9. PubMed ID: 25469058
[TBL] [Abstract][Full Text] [Related]
48. Prion protein and species barriers in the transmissible spongiform encephalopathies.
Priola SA
Biomed Pharmacother; 1999; 53(1):27-33. PubMed ID: 10221165
[TBL] [Abstract][Full Text] [Related]
49. A systematic investigation of production of synthetic prions from recombinant prion protein.
Schmidt C; Fizet J; Properzi F; Batchelor M; Sandberg MK; Edgeworth JA; Afran L; Ho S; Badhan A; Klier S; Linehan JM; Brandner S; Hosszu LL; Tattum MH; Jat P; Clarke AR; Klöhn PC; Wadsworth JD; Jackson GS; Collinge J
Open Biol; 2015 Dec; 5(12):150165. PubMed ID: 26631378
[TBL] [Abstract][Full Text] [Related]
50. Propagation and Dissemination Strategies of Transmissible Spongiform Encephalopathy Agents in Mammalian Cells.
Heumüller SE; Hornberger AC; Hebestreit AS; Hossinger A; Vorberg IM
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328330
[TBL] [Abstract][Full Text] [Related]
51. Generating Bona Fide Mammalian Prions with Internal Deletions.
Munoz-Montesino C; Sizun C; Moudjou M; Herzog L; Reine F; Chapuis J; Ciric D; Igel-Egalon A; Laude H; Béringue V; Rezaei H; Dron M
J Virol; 2016 Aug; 90(15):6963-6975. PubMed ID: 27226369
[TBL] [Abstract][Full Text] [Related]
52. Biological effects and use of PrPSc- and PrP-specific antibodies generated by immunization with purified full-length native mouse prions.
Petsch B; Müller-Schiffmann A; Lehle A; Zirdum E; Prikulis I; Kuhn F; Raeber AJ; Ironside JW; Korth C; Stitz L
J Virol; 2011 May; 85(9):4538-46. PubMed ID: 21345946
[TBL] [Abstract][Full Text] [Related]
53. Prion-like disorders and Transmissible Spongiform Encephalopathies: An overview of the mechanistic features that are shared by the various disease-related misfolded proteins.
Eraña H; Venegas V; Moreno J; Castilla J
Biochem Biophys Res Commun; 2017 Feb; 483(4):1125-1136. PubMed ID: 27590581
[TBL] [Abstract][Full Text] [Related]
54. Prion protein interconversions.
Caughey B
Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):197-200; discussion 200-2. PubMed ID: 11260800
[TBL] [Abstract][Full Text] [Related]
55. Unraveling the details of prion (con)formation(s): recent advances by mass spectrometry.
Principe S; Maras B; Schininà ME; Pocchiari M; Cardone F
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):697-707. PubMed ID: 18729021
[TBL] [Abstract][Full Text] [Related]
56. Cellular aspects of prion replication in vitro.
Grassmann A; Wolf H; Hofmann J; Graham J; Vorberg I
Viruses; 2013 Jan; 5(1):374-405. PubMed ID: 23340381
[TBL] [Abstract][Full Text] [Related]
57. Prion diseases of humans and farm animals: epidemiology, genetics, and pathogenesis.
Aguzzi A
J Neurochem; 2006 Jun; 97(6):1726-39. PubMed ID: 16805779
[TBL] [Abstract][Full Text] [Related]
58. A 25 nm virion is the likely cause of transmissible spongiform encephalopathies.
Manuelidis L
J Cell Biochem; 2007 Mar; 100(4):897-915. PubMed ID: 17044041
[TBL] [Abstract][Full Text] [Related]
59. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
60. Prions and their partners in crime.
Caughey B; Baron GS
Nature; 2006 Oct; 443(7113):803-10. PubMed ID: 17051207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
